Subsequently, we found that miR-367 targeted LPA1 expression and overexpression of miR-367 downregulated LPA1 expression to repress proliferation, invasion, and angiogenesis of ovarian cancer cells, thereby inhibiting ovarian cancer progression. Here, LPAR1 is linked to ovarian cancer.